An Optimal Care Coordination Model for Medicaid Patients with Lung Cancer: Finalization of the Model and Implications for Clinical Practice in the United States

Click to increase image sizeClick to decrease image size

Acknowledgments

Funding for the OCCM initiative was provided by the Bristol Myers Squibb Foundation. The authors are grateful for the contributions of the Advisory Committee and the Technical Expert Panel toward the development and testing of the OCCM. The following persons contributed to the analysis of the OCCM beta testing data: Meredith A. Ray, PhD, MPH; Vikki G. Nolan, DSc, MPH; Mary Catherine Nalan, MPH; and Walter Stevens, MPH (Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis); and Nicholas R. Faris, MDiv (Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center).

The authors thank all patients and participating staff at the testing sites for their contributions toward testing the beta version of the OCCM. The seven testing sites were AdventHealth Daytona Beach (formerly Florida Hospital Memorial Medical Center), Florida; Advocate Lutheran General Hospital, Lutheran General Cancer Institute, Illinois; Ascension Wheaton Memorial Medical Center, Wisconsin; Genesis HealthCare System, Genesis Cancer Care Center, Ohio; Cowell Family Cancer Center, Munson Healthcare, Michigan; Northwest Medical Specialties, Washington; and Southern Ohio Medical Center, Ohio.

Medical writing support was provided by Melissa Furtado, MPH, and Nicola West, BSc (Hons), CMPP, of Cactus Life Sciences (part of Cactus Communications) and funded by the Bristol Myers Squibb Foundation. The authors retained full control over the content of this article and approved the final version for submission.

Additional information

Notes on contributors

Randall A. Oyer

Randall A. Oyer, MD, is medical director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, Pa. Christopher S. Lathan, MD, MS, MPH, is medical director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, Mass., and assistant professor of medicine Harvard Medical School, Boston, Mass. Matthew P. Smeltzer, PhD, MStat, is assistant professor in the Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn. Amanda Kramar is chief learning officer and Leigh M. Boehmer, PharmD, BCOP is chief medical officer, Association of Community Cancer Centers, Rockville, Md. Thomas M. Asfeldt, MBA, RN, BAN, was formerly the director, Outpatient Cancer Services and Radiation Oncology, Sanford USD Medical Center, Sioux Falls, S.D., and Sanford Health Cancer Center, Worthington, Minn.

Christopher S. Lathan

Randall A. Oyer, MD, is medical director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, Pa. Christopher S. Lathan, MD, MS, MPH, is medical director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, Mass., and assistant professor of medicine Harvard Medical School, Boston, Mass. Matthew P. Smeltzer, PhD, MStat, is assistant professor in the Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn. Amanda Kramar is chief learning officer and Leigh M. Boehmer, PharmD, BCOP is chief medical officer, Association of Community Cancer Centers, Rockville, Md. Thomas M. Asfeldt, MBA, RN, BAN, was formerly the director, Outpatient Cancer Services and Radiation Oncology, Sanford USD Medical Center, Sioux Falls, S.D., and Sanford Health Cancer Center, Worthington, Minn.

Matthew P. Smeltzer

Randall A. Oyer, MD, is medical director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, Pa. Christopher S. Lathan, MD, MS, MPH, is medical director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, Mass., and assistant professor of medicine Harvard Medical School, Boston, Mass. Matthew P. Smeltzer, PhD, MStat, is assistant professor in the Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn. Amanda Kramar is chief learning officer and Leigh M. Boehmer, PharmD, BCOP is chief medical officer, Association of Community Cancer Centers, Rockville, Md. Thomas M. Asfeldt, MBA, RN, BAN, was formerly the director, Outpatient Cancer Services and Radiation Oncology, Sanford USD Medical Center, Sioux Falls, S.D., and Sanford Health Cancer Center, Worthington, Minn.

Amanda Kramar

Randall A. Oyer, MD, is medical director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, Pa. Christopher S. Lathan, MD, MS, MPH, is medical director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, Mass., and assistant professor of medicine Harvard Medical School, Boston, Mass. Matthew P. Smeltzer, PhD, MStat, is assistant professor in the Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn. Amanda Kramar is chief learning officer and Leigh M. Boehmer, PharmD, BCOP is chief medical officer, Association of Community Cancer Centers, Rockville, Md. Thomas M. Asfeldt, MBA, RN, BAN, was formerly the director, Outpatient Cancer Services and Radiation Oncology, Sanford USD Medical Center, Sioux Falls, S.D., and Sanford Health Cancer Center, Worthington, Minn.

Leigh M. Boehmer

Randall A. Oyer, MD, is medical director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, Pa. Christopher S. Lathan, MD, MS, MPH, is medical director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, Mass., and assistant professor of medicine Harvard Medical School, Boston, Mass. Matthew P. Smeltzer, PhD, MStat, is assistant professor in the Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn. Amanda Kramar is chief learning officer and Leigh M. Boehmer, PharmD, BCOP is chief medical officer, Association of Community Cancer Centers, Rockville, Md. Thomas M. Asfeldt, MBA, RN, BAN, was formerly the director, Outpatient Cancer Services and Radiation Oncology, Sanford USD Medical Center, Sioux Falls, S.D., and Sanford Health Cancer Center, Worthington, Minn.

Thomas M. Asfeldt

Randall A. Oyer, MD, is medical director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, Pa. Christopher S. Lathan, MD, MS, MPH, is medical director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, Mass., and assistant professor of medicine Harvard Medical School, Boston, Mass. Matthew P. Smeltzer, PhD, MStat, is assistant professor in the Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn. Amanda Kramar is chief learning officer and Leigh M. Boehmer, PharmD, BCOP is chief medical officer, Association of Community Cancer Centers, Rockville, Md. Thomas M. Asfeldt, MBA, RN, BAN, was formerly the director, Outpatient Cancer Services and Radiation Oncology, Sanford USD Medical Center, Sioux Falls, S.D., and Sanford Health Cancer Center, Worthington, Minn.